The introduction of innovative medical treatments in medicine for a reconstructive and regenerative medicine as an opportunity to achieve a competitive advantage. (Q123082): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claim: summary (P836): The aim of the project is to implement an innovative technological process for the collection and transfer of fatty cells or stem cells and the placing on the market of innovative, reconstructive and regenerative medicine services. The achievement of the objective (s) will be achieved through the implementation of investments related to the purchase of: Equipment for the collection of fatty cells and for the separation of stem cells in a close...)
(‎Created claim: summary (P836): The aim of the project is to implement an innovative technological process for the acquisition and transfer of fat cells or stem cells and introduce innovative services in the field of reconstructive medicine. It will be possible to achieve the above-mentioned objective by carrying out an investment related to the purchase: —devices for the collection of fat cells and stem cell separation in one closed system – system for high-frequency and reso...)
Property / summary
 
The aim of the project is to implement an innovative technological process for the acquisition and transfer of fat cells or stem cells and introduce innovative services in the field of reconstructive medicine. It will be possible to achieve the above-mentioned objective by carrying out an investment related to the purchase: —devices for the collection of fat cells and stem cell separation in one closed system – system for high-frequency and resolution RF -USG liposuction procedures. The innovative process will consist of simultaneously: obtaining fat cells and isolating stem cells during liposuction in a closed system in a gentle waterjet (WAL) method, grafting the material to the target site with a simultaneous procedure for shrinking skin coatings in the area of material collection by subcutaneous radiofracture. In addition, monitoring of the entire therapeutic process will be introduced for the patient’s safety. (English)
Property / summary: The aim of the project is to implement an innovative technological process for the acquisition and transfer of fat cells or stem cells and introduce innovative services in the field of reconstructive medicine. It will be possible to achieve the above-mentioned objective by carrying out an investment related to the purchase: —devices for the collection of fat cells and stem cell separation in one closed system – system for high-frequency and resolution RF -USG liposuction procedures. The innovative process will consist of simultaneously: obtaining fat cells and isolating stem cells during liposuction in a closed system in a gentle waterjet (WAL) method, grafting the material to the target site with a simultaneous procedure for shrinking skin coatings in the area of material collection by subcutaneous radiofracture. In addition, monitoring of the entire therapeutic process will be introduced for the patient’s safety. (English) / rank
 
Normal rank
Property / summary: The aim of the project is to implement an innovative technological process for the acquisition and transfer of fat cells or stem cells and introduce innovative services in the field of reconstructive medicine. It will be possible to achieve the above-mentioned objective by carrying out an investment related to the purchase: —devices for the collection of fat cells and stem cell separation in one closed system – system for high-frequency and resolution RF -USG liposuction procedures. The innovative process will consist of simultaneously: obtaining fat cells and isolating stem cells during liposuction in a closed system in a gentle waterjet (WAL) method, grafting the material to the target site with a simultaneous procedure for shrinking skin coatings in the area of material collection by subcutaneous radiofracture. In addition, monitoring of the entire therapeutic process will be introduced for the patient’s safety. (English) / qualifier
 
point in time: 21 October 2020
Timestamp+2020-10-21T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 10:40, 21 October 2020

Project in Poland financed by DG Regio
Language Label Description Also known as
English
The introduction of innovative medical treatments in medicine for a reconstructive and regenerative medicine as an opportunity to achieve a competitive advantage.
Project in Poland financed by DG Regio

    Statements

    0 references
    373,500.0 zloty
    0 references
    89,640.0 Euro
    13 January 2020
    0 references
    830,000.0 zloty
    0 references
    199,200.0 Euro
    13 January 2020
    0 references
    45.0 percent
    0 references
    1 October 2018
    0 references
    31 January 2020
    0 references
    BUSZKA-WIEPRZYCKA KAMILLA NIEPUBLICZNY ZESPÓŁ OPIEKI ZDROWOTNEJ CENTRUM ZDROWIA SANVITA
    0 references
    0 references

    50°12'25.9"N, 18°39'49.3"E
    0 references
    Celem projektu jest wdrożenie innowacyjnego procesu technologicznego w zakresie pozyskiwania i transferu komórek tłuszczowych lub komórek macierzystych i wprowadzenie na rynek innowacyjnych usług w zakresie medycyny rekonstrukcyjno-regeneracyjnej. Osiągnięcie w/w celu możliwe będzie przez realizację inwestycji związanej z zakupem: -urządzenia do poboru komórek tłuszczowych i separacji komórek macierzystych w jednym zamkniętym systemie -systemu do zabiegów liposukcji RF -USG wysokiej częstotliwości i rozdzielczości. Innowacyjny proces polegał będzie na jednoczesnym: pozyskaniu komórek tłuszczowych i wyizolowaniu komórek macierzystych w czasie liposukcji w zamkniętym systemie w metodzie delikatnego strumienia wody (WAL), przeszczepieniu materiału w miejsce docelowe z jednoczesną procedurą obkurczania powłok skórnych w obszarze pobrania materiału za pomocą podskórnej radiofrekwencji. Ponadto dla bezpieczeństwa pacjenta wprowadzony zostanie monitoring całego procesu leczniczego. (Polish)
    0 references
    The aim of the project is to implement an innovative technological process for the acquisition and transfer of fat cells or stem cells and introduce innovative services in the field of reconstructive medicine. It will be possible to achieve the above-mentioned objective by carrying out an investment related to the purchase: —devices for the collection of fat cells and stem cell separation in one closed system – system for high-frequency and resolution RF -USG liposuction procedures. The innovative process will consist of simultaneously: obtaining fat cells and isolating stem cells during liposuction in a closed system in a gentle waterjet (WAL) method, grafting the material to the target site with a simultaneous procedure for shrinking skin coatings in the area of material collection by subcutaneous radiofracture. In addition, monitoring of the entire therapeutic process will be introduced for the patient’s safety. (English)
    21 October 2020
    0 references

    Identifiers

    RPSL.03.02.00-24-0109/18
    0 references